Linifanib is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR, CSF-1R, Flt-1/3 and PDGFR with IC50 of 4 nM, 3 nM, 3 nM/4 nM and 66 nM respectively.
仅供研究使用。 我们不向患者出售。
化学信息
名称 | Linifanib |
Iupac 化学名称 | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea |
同义词 | ABT-869; AL-39324; ABT 869; ABT869; AL 39324; AL39324 |
英文同义词 | ABT-869; AL-39324; ABT 869; ABT869; AL 39324; AL39324 |
分子式 | C21H18FN5O |
分子量 | 375.399 |
Smile | CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N |
InChiKey | MPVGZUGXCQEXTM-UHFFFAOYSA-N |
InChi | InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28) |
Cas号 | 796967-16-3 |
相关CAS号 | |
外观性状 | Solid powder |
纯度 | 98% |
存储 | -20 ºC for 3 years |
可溶性 | Soluble in DMSO |
处理方式 | |
运输条件 | Shipped under ambient temperature |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |